Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Role of the Presenilin1mediated Cleavage of E-cadherin Updated On: Jan. 19, 2025
Alzheimer's Disease Research Grant

Role of the Presenilin1mediated Cleavage of E-cadherin

BFF logo

Principal Investigator

Philippe Marambaud, PhD

Icahn School of Medicine at Mount Sinai

New York, NY, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$200,000

Active Dates

April 01, 2002 - March 31, 2004

Grant ID

A2002061

Summary

Mutations in presenilin-1 (PS1) are responsible for familial Alzheimer’s disease (FAD), also known as early-onset Alzheimer’s disease. PS1 is found at the plasma membrane and is involved in cell-cell contacts. It interacts with E-cadherin, a cell surface molecule that facilitates cell-cell adhesions and has a crucial role in the structure of the synapse, the region involved in neuron communication. E-cadherin forms complexes with cytosolic proteins, like catenins, to link the actin cytoskeleton. The remodeling of cell-cell interactions is a central determinant for many functions, including tissue repair, cell migration and cell death. The molecular mechanisms involved in the disassembly of cell-cell associations are not clearly understood. It has been shown E-cadherin processing is mediated by PS1/gamma secretase activity. Dr. Marambaude is investigating whether PS1-mediated cleavage of E-cadherin disconnects the cadherin with the cytoskeleton and plays a role in the disassembly of cell-cell adhesions. He also plans to study the signaling pathways that are activated by the PS1/gamma secretase-mediated processing of E-cadherin and the subsequent disassembly of cadherin/catenin complexes. Finally, he will examine whether mutated PS1 in FAD abnormally affects its activity to cleave E-cadherin and thereby participating in the neuronal loss observed in Alzheimer’s disease. This project will help to determine the usefulness of treatments using gamma-secretase inhibitors in altering the E-cadherin-dependent adhesion and signaling systems.